拮抗血管增殖在乳腺癌治疗中的应用进展
摘要
血管增殖在肿瘤组织的增殖、浸润、转移过程中发挥重要作用。肿瘤诱导的新生血管常常结构异常，具有不规则分支、动静脉短路，有较高的通透性以及较高的组织静水压等特点。肿瘤细胞介导的血管增殖涉及机体的分子及细胞水平的参与调控。
出处
《中华临床医师杂志（电子版）》
CAS
2011年第3期97-101,共5页
Chinese Journal of Clinicians(Electronic Edition)
参考文献29
-
1Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors.Nat Med,2003,9(6):669-676.
-
2Fox SB,Generali DG,Harris AL.Breast tumour angiogenesis.Breast Cancer Res,2007,9(6):216.
-
3Dvorak HF.Angiogenesis:update 2005.J Thromb Haemost,2005,3(8):1835-1842.
-
4Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target.Nature,2005,438(7070):967-974.
-
5Longo R,Gasparini G.Anti-VEGF therapy:the search for clinical biomarkers.Expert Rev Mol Diagn,2008,8(3):301-314.
-
6Ferrara N,Hillan KJ,Gerber HP,et al.Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer.Nat Rev Drug Discov,2004,3(5):391-400.
-
7Miller KD,Chap LI,Holmes FA,et al.Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.J Clin Oncol,2005,23(4):792-799.
-
8Miller K,Wang M,Gralow J,et al.Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.N Engl J Med,2007,357(26):2666-2676.
-
9Miles D,Chan A,Romieu G,et al.Randomized,double-blind,placebo-controlled,phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or etastatic breast cancer(mBC):AVADO.Presented at:the American Society of Clinical Oncology Annual Meeting,2008.
-
10O'Shaughnessy JA,Brufsky AM.RiBBON 1 and RiBBON 2:phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.Clin Breast Cancer,2008,8(4):370-373.
-
1宋晓玉,胡新民,李力,范仲元.恶性肿瘤特异性生长因子对恶性肿瘤的诊断效率[J].预防医学情报杂志,2003,19(5):462-462.
-
2余之刚,杨其峰,王建新,付勤烨,孙靖中.淋巴结阳性乳腺癌的血管增殖与蒽环类药物相关性的研究[J].中国肿瘤临床,2002,29(4):268-272. 被引量：1
-
3林燕,孙强,管珩.贝伐单抗在乳腺癌治疗中的应用[J].中国普通外科杂志,2011,20(11):1255-1258.
-
4朱立新,耿小平.血管新生与肝细胞肝癌[J].肝胆外科杂志,2001,9(1):69-70. 被引量：1
-
5王成刚,余之刚,孙靖中.血管增殖与乳腺癌预后的相关性研究[J].肿瘤防治杂志,2003,10(2):133-136. 被引量：3
-
6于笑涵,杨方.Endoglin与肿瘤的血管增殖[J].中国煤炭工业医学杂志,2011,14(8):1258-1260. 被引量：1
-
7张刚利,吉宏明,张汉伟.血管增殖在垂体腺瘤侵袭性生长中的作用[J].山西医科大学学报,2005,36(4):427-429. 被引量：1
-
8陈卫峰,莫立根,吴倩岚.贝伐单抗治疗复发性胶质母细胞瘤的研究进展[J].中国神经肿瘤杂志,2012,10(2):117-120. 被引量：7
-
9刘文娟,董鹏,王滨,李玉意,崔慧.外生型肝细胞癌及肝血管瘤的CT诊断[J].中国中西医结合影像学杂志,2008,6(2):88-90. 被引量：3
-
10徐向东,王海鹏.健康体检人群恶性肿瘤特异性生长因子的检测与分析[J].标记免疫分析与临床,2010,17(3):190-191. 被引量：5
